Home » Key Clinical Research Articles Global Medical Discovery » Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes

Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes

Justo GA, Bitencourt MA, Pasquini R, Castelo-Branco MT, Almeida-Oliveira A, Diamond HR, Rumjanek VM.

Ann Hematol. 2014 May;93(5):761-7.

Departamento de Bioquímica, IBRAG, UERJ, Rio de Janeiro, Brazil, [email protected]

 

Abstract

Fanconi anemia (FA), a rare genetic disease in which patients’ life is compromised mainly by hematological abnormalities and cancer prone, seems to be affected by subtle immune cell irregularities. Knowing that Fanconi anemia presents developmental abnormalities and, based on recent reports, suggesting that natural killer (NK) CD56(dim) and NK CD56 (bright) correspond to sequential differentiation pathways, we investigated if there were changes on the total number of NK cells and subsets as well as on T CD4 and T CD8 lymphocytes and their ratio. A large sample of Fanconi anemia patients (n = 42) was used in this work, and the results were correlated to clinical hematological status of these patients. Among Fanconi anemia patients, a decreased proportion of TCD8(+) and NK CD56(dim)CD16(+) cells were observed when compared to healthy controls as well as an imbalance of the subsets NK lymphocytes. Data suggest that Fanconi anemia patients might have a defective cytotoxic response due to the lower number of cytotoxic cells as well as impairment in the differentiation process of the NK cells subsets which may be directly related to impairment of the immune surveillance observed in these patients.

Go To PubMed